Computational Protein Design for COVID-19 Research and Emerging Therapeutics
ACS Central Science · 26.04.2023 · 9 (4) · 602-613
DOI: 10.1021/acscentsci.2c01513 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Central Science, online erschienen am 20.03.2023. Verfasst von Parismita Kalita und 2 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Structural Biophysics Laboratory, Department of Biochemistry, North-Eastern Hill University, Shillong 793022, India. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As the world struggles with the ongoing COVID-19 pandemic, unprecedented obstacles have continuously been traversed as new SARS-CoV-2 variants continually emerge. Infectious disease outbreaks are unavoidable, but the knowledge gained from the successes and failures will help create a robust health management system to deal with such pandemics. Previously, scientists required years to develop diagnostics, therapeutics, or vaccines; however, we have seen that, with the rapid deployment of high-throughput technologies and unprecedented scientific collaboration worldwide, breakthrough discoveries can be accelerated and insights broadened. Computational protein design (CPD) is a game-changing new technology that has provided alternative therapeutic strategies for pandemic management. In addition to the development of peptide-based inhibitors, miniprotein binders, decoys, biosensors, nanobodies, and monoclonal antibodies, CPD has also been used to redesign native SARS-CoV-2 proteins and human ACE2 receptors. We discuss how novel CPD strategies have been exploited to develop rationally designed and robust COVID-19 treatment strategies.
Autor:innen und Institutionen
- Molecular and Structural Biophysics Laboratory, Department of Biochemistry, North-Eastern Hill University, Shillong 793022, India.
- Regional Director's Office, Indira Gandhi National Open University, Regional Centre Kohima, Kenuozou, Kohima 797001, India.
- Laboratory for Computational Biology & Biomolecular Design, School of Biochemical Engineering, Indian Institute of Technology (BHU), Varanasi 221005, Uttar Pradesh, India.
ORCID-Profile: Timir Tripathi, Aditya K Padhi
Zitieren
APA
Kalita, P., Tripathi, T., & Padhi, A. K. (2023). Computational Protein Design for COVID-19 Research and Emerging Therapeutics. ACS Central Science, 9(4), 602-613. https://doi.org/10.1021/acscentsci.2c01513
Vancouver
Kalita P, Tripathi T, Padhi AK. Computational Protein Design for COVID-19 Research and Emerging Therapeutics. ACS Central Science. 2023;9(4):602-613. doi:10.1021/acscentsci.2c01513
BibTeX
@article{Kalita2023,
author = {Kalita, Parismita and Tripathi, Timir and Padhi, Aditya K},
title = {Computational Protein Design for COVID-19 Research and Emerging Therapeutics},
journal = {ACS Central Science},
year = {2023},
volume = {9},
number = {4},
pages = {602--613},
doi = {10.1021/acscentsci.2c01513}
}
EUVIMED